Eagle Pharmaceuticals
EGRX
#10401
Rank
NZ$11.37 M
Marketcap
NZ$0.88
Share price
2.00%
Change (1 day)
-40.08%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$11.37 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of NZ$11.37 Million. This makes Eagle Pharmaceuticals the world's 10401th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$11.37 M-9.99%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$11.15 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$866.24 B 7,615,285.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.42 B 1,489,335.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$437.23 B 3,843,757.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$58.76 B 516,539.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$290.10 B 2,550,324.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.540 T 13,544,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$177.61 B 1,561,362.69%๐Ÿ‡บ๐Ÿ‡ธ USA